Ipratropiumbromid/Salbutamol Neutec (Ipratropium Bromide, Salbutamol)

Ipratropium bromide blocks muscarinic receptors, preventing acetylcholine‑induced bronchoconstriction, while salbutamol stimulates β2‑adrenergic receptors, increasing cyclic AMP and relaxing airway smooth muscle. Together they produce additive bronchodilation.

The prescribed dose is determined by the treating physician based on the patient’s severity of disease, response to therapy, and clinical guidelines. Dosage instructions are provided on the prescription label.

Safety in pregnancy and lactation has not been fully established. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and under the guidance of a healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Compared with single‑agent bronchodilators, the combination offers dual mechanisms—anticholinergic and β2‑agonist—providing greater bronchodilation and symptom control, especially in patients who need both pathways targeted. It is often preferred when monotherapy does not achieve adequate relief.

Store the inhalation product at room temperature, below 25 °C, in its original packaging. Keep it away from moisture, heat sources and direct sunlight to maintain stability and potency.

The medication is delivered via a metered‑dose inhaler or nebulizer, as directed by the prescriber. The patient inhales the dose deeply, holds the breath briefly, and then exhales, following the specific device instructions.

Serious risks include paradoxical bronchospasm, severe tachyarrhythmias, angioedema, and significant changes in blood glucose or potassium levels. Patients should seek immediate medical attention if they experience worsening breathing, chest pain, swelling of the face or throat, or irregular heartbeats.

Individuals with a known hypersensitivity to ipratropium, salbutamol, or any formulation components should avoid this product. Caution is also advised for patients with certain cardiac conditions, uncontrolled hypertension, or severe diabetes, and it should be used only under medical supervision.